Dr Reddy's Laboratories reported a 14.5 per cent rise in consolidated Q2 profit to Rs 1,437 crore, driven by strong branded sales. Revenue grew to Rs 8,805 crore, with robust performance in Europe, India, and emerging markets offsetting North America declines
